Delivery Order SPE2DX22D0010-SPE2D826FBJ66
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Nucynta ER Tabs 200mg, a controlled-release pain management pharmaceutical. This non-set-aside, competitively awarded contract is valued at $6,062.41 with a firm fixed price structure and an ultimate completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, and the place of...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on December 2, 2025, with a ceiling value of $6,005.34 and an ultimate completion date of December 3, 2025. The contract does not carry a set-aside designation, and performance is based at AmerisourceBergen's corporate office...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nucynta ER Tabs 250mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, valued at $8,619.04 with an ultimate completion date of June 2, 2025, represents a non-competitive award executed under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,101.84 for Nucynta ER Tabs 250mg, a pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,119.13 to supply Nucynta ER (extended-release) 150mg tablets, with delivery expected by December 15, 2025. This firm fixed-price delivery order, awarded on December 12, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,937.42, was competitively awarded without set-aside designation and is scheduled for completion by December 10, 2025. The awardee will perform work at its corporate office in Conshohocken, Pennsylvania, leveraging its established position as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Nucynta ER Tabs 200mg, a controlled-release opioid pain management pharmaceutical. The contract, awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, carries a ceiling value of $2,186.26 and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitive award issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Nucynta ER 100 mg tablets in quantities of 60 units. This is a firm fixed price delivery order valued at $4,275.36 with an ultimate completion date of December 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $4,749.30. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBJ66Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Nucynta ER Tabs 200mg, a controlled-release pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,228.90 and an ultimate completion date of December 1, 2025. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The company's SPE2DX prime contract vehicle functions as a comprehensive global pharmaceutical support mechanism enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply needs through the broader DLA framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 11/27/25 |